IntraLase Announces First Use of FS Laser for Advanced Corneal Transplant Surgery

Jan. 26, 2006--IntraLase Corp. (Nasdaq:ILSE) today announced the first corneal transplant cases using the IntraLase(R) FS laser have been successfully performed in patients, marking the first major technology advancement in corneal transplant surgery in more than five years. The use of IntraLase's ultra-fast laser to create a contoured, full-thickness corneal resection in preparation for corneal transplant has the potential to make corneal transplantation a safer, more precise procedure as the all-laser approach gains favor among transplant surgeons. Full global launch of this new therapeutic application is expected in Fall 2006.

Three of the country's leading ophthalmic institutes, Bascom Palmer Eye Institute at the University of Miami, Corneal Research Foundation of America of Indianapolis and the University of California Irvine, Department of Ophthalmology, are among the first in the country to adopt all-laser corneal transplant surgery. They've affirmed IntraLase's ability to improve the surgery, considered the last resort for patients facing blindness resulting from severe corneal disease.

Read more on "IntraLase Announces First Use of FS Laser for Advanced Corneal Transplant Surgery"...